Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)

China flag China · Delayed Price · Currency is CNY
11.35
+0.12 (1.07%)
Feb 27, 2026, 4:00 PM EST
-14.21%
Market Cap 24.80B
Revenue (ttm) 4.74B
Net Income (ttm) 935.80M
Shares Out 2.23B
EPS (ttm) 0.42
PE Ratio 26.62
Forward PE 28.51
Dividend 0.27 (2.38%)
Ex-Dividend Date Jun 10, 2025
Volume 19,567,490
Average Volume 17,877,636
Open 11.16
Previous Close 11.23
Day's Range 11.07 - 11.38
52-Week Range 9.71 - 14.74
Beta 0.17
RSI 56.77
Earnings Date Mar 31, 2026

About SHE:301301

Yili Chuanning Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally. The company offers antibiotic intermediates comprising erythromycin thiofluorate; cephalosporin intermediates consisting of 7-aminocephalosporanic acid (7-ACA), 7-amino-3-deacetoxycephalosporinic acid (7-ADCA), and D-7ACA; penicillin intermediates, such as 6-aminopenicillanic acid (6-APA) and penicillin G potassium salt; urso... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 3,184
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301301
Full Company Profile

Financial Performance

In 2024, SHE:301301's revenue was 5.76 billion, an increase of 19.38% compared to the previous year's 4.82 billion. Earnings were 1.40 billion, an increase of 48.88%.

Financial Statements

News

There is no news available yet.